help button home button
AJRCCM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

Published ahead of print on March 5, 2003, doi:10.1164/rccm.200212-1508OC
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Online Supplement
Right arrow All Versions of this Article:
200212-1508OCv1
167/11/1504    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Korsgren, M.
Right arrow Articles by Greiff, L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Korsgren, M.
Right arrow Articles by Greiff, L.
American Journal of Respiratory and Critical Care Medicine Vol 167. pp. 1504-1508, (2003)
© 2003 American Thoracic Society


Original Article

Neural Expression and Increased Lavage Fluid Levels of Secretoneurin in Seasonal Allergic Rhinitis

Magnus Korsgren, Jonas S. Erjefält, Josef Hinterhölzl, Reiner Fischer-Colbrie, Cecilia Ahlström Emanuelsson, Morgan Andersson, Carl G. A. Persson, Alan Mackay-Sim, Frank Sundler and Lennart Greiff

Departments of Clinical Pharmacology and Otorhinolaryngology, University Hospital, Department of Physiological Sciences, Lund University, Lund, Sweden; Department of Pharmacology, Innsbruck University, Innsbruck, Austria; and School of Biomolecular and Biomedical Science, Griffith University, Brisbane, Australia

Correspondence and requests for reprints should be addressed to Dr. Magnus Korsgren, M.D., Department of Clinical Pharmacology, University Hospital, SE-221 85 Lund, Sweden. E-mail: magnus.korsgren{at}klinfarm.lu.se

Secretoneurin is a neuropeptide potentially involved in migration of eosinophils, monocytes, and dendritic cells. Whether secretoneurin is present in the human airway mucosa and whether it is released at ongoing allergic airway inflammation is currently unknown. In patients with allergic rhinitis, we have explored the occurrence of secretoneurin in nasal mucosal biopsies and lavage fluids before and during natural allergen exposure. Immunohistochemical analysis revealed an abundance of nerves displaying secretoneurin immunoreactivity, which were distributed predominantly around blood vessels and submucosal glands. A majority of nerve fibers containing vesicular acetylcholine transporter, tyrosine hydroxylase, calcitonin gene–related peptide, and vasoactive intestinal peptide were also secretoneurin-immunoreactive, indicating a localization of secretoneurin in cholinergic, adrenergic, and sensory nerves. Lavage fluid levels of secretoneurin were increased at allergen exposure (p < 0.01–0.05). Levels of secretoneurin did not correlate with eosinophil cationic protein ({rho} = 0.1, p = 0.7). We conclude that secretoneurin has a widespread occurrence in nasal mucosal nerves of patients with seasonal allergic rhinitis and that increased nasal lavage fluid levels of secretoneurin may characterize ongoing allergen exposure. These data favor a role of secretoneurin in the local traffic of immune cells in human airway mucosa.

Key Words: allergic airway inflammation • neuropeptides • eosinophils




This article has been cited by other articles:


Home page
Am. J. Respir. Crit. Care Med.Home page
M. J. Tobin
Asthma, Airway Biology, and Nasal Disorders in AJRCCM 2003
Am. J. Respir. Crit. Care Med., January 15, 2004; 169(2): 265 - 276.
[Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Proc. Am. Thorac. Soc. Am. J. Respir. Cell Mol. Biol.
Copyright © 2003 American Thoracic Society
  ATS State of the Art 2009